AVIYA is a specialized early-stage clinical development firm.

We deliver innovative and robust clinical development solutions from “pre-clinical” through phase II.

AVIYA provides upfront strategic planning and feasibility assessments, clinical trial development and operational services, regulatory and medical report writing services, due diligence and licensing evaluation services.

AVIYA is focused on important therapeutic areas, such diabetes, metabolic diseases, obesity and osteoporosis.

AVIYA is committed to creating value by measurably reducing risk for early stage biopharmaceutical companies and partner organizations.